Health Economics & Reimbursement
Companies in the pharmaceutical and medical technology industries and manufacturers of medical devices face unique challenges, especially in the areas of innovation funding, market access and reimbursement.
Fast and secure market access is critical to the success of a new drug or medical device. Oberender supports you in the development of a market access strategy, assists you with the necessary formalities (e.g. OPS applications, NUB application procedures) and helps you establish the necessary contacts with relevant decision-makers and operators.
The objective is always to compare different market access routes and implement the best market access strategy for the specific product. Oberender helps clients develop an understanding of the decision-making processes for users, e.g. in hospitals.
Oberender develops a market-oriented strategy together with the client to secure the funding of innovative business models, pharmaceuticals and/or medical devices – in both the short term and for the long run. Due to the different formalities and terms, funding options may change multiple times before maximum care is ensured.
Oberender also supports clients in the pharmaceutical and medical devices industry after market access to determine further market potential and promote communication with operators and other users. Oberender utilizes it proximity to the inpatient sector to make connections with innovative and established companies.
Physician, Business Mediator, Board Member Oberender AG
Elsenheimerstr. 59, 80687 Munich, Germany
Phone: +49 (0)89 8207516 - 0
Fax: +49 (0)89 8207516 – 9